Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Wheeler

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.
The Journal of Biological Chemistry|January 10, 1981
Glucocorticoid receptor activation and inactivation in cultured human lymphocytesR H Wheeler, K L Leach, A C La Forest, et al.
Cancer Treatment Reports|August 1, 1980
Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinomaR H Wheeler, M K Liepman, S R Baker, et al.
Cancer Drug Delivery|January 1, 1984
Radionuclide localization of intraarterial infusions in head and neck cancerS R Baker, R H Wheeler, H A Ziessman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neckS A Spencer, J Harris, R H Wheeler, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiationB Weppelmann, R H Wheeler, G E Peters, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological dataM N Saleh, A F LoBuglio, R H Wheeler, et al.
Surgery|October 1, 1981
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoidsF E Eckhauser, L C Argenta, W E Strodel, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.
The Journal of Biological Chemistry|January 10, 1981
Glucocorticoid receptor activation and inactivation in cultured human lymphocytesR H Wheeler, K L Leach, A C La Forest, et al.
Cancer Treatment Reports|August 1, 1980
Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinomaR H Wheeler, M K Liepman, S R Baker, et al.
Cancer Drug Delivery|January 1, 1984
Radionuclide localization of intraarterial infusions in head and neck cancerS R Baker, R H Wheeler, H A Ziessman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neckS A Spencer, J Harris, R H Wheeler, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiationB Weppelmann, R H Wheeler, G E Peters, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological dataM N Saleh, A F LoBuglio, R H Wheeler, et al.
Surgery|October 1, 1981
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoidsF E Eckhauser, L C Argenta, W E Strodel, et al.
Pageof 8